Data Showcase Imaging Agent Utility in Lung Cancer Surgery

The data that led to the December approval of the imaging agent pafolacianine (Cytalux), which helps surgeons identify cancerous tissue during lung cancer surgery, are now available. The recent report, published online in the Journal of Thoracic and Cardiovascular Surgery, showed that pafolacianine led to clinically significant changes in more than half of surgeries, which […]

Glioblastoma: Immunotherapy-loaded gel stops cancer in mice

Glioblastoma is a form of brain cancer that has very low survivability rates. This is partly due to the fact that glioblastoma cancers evade detection by the immune system, and spread aggressively. Many recent improvements in cancer survivability rates are due to the use of immunotherapies, but it is difficult for these to cross the […]

WHO claims phrase 'shames' drunken thugs

Now you can’t even say ‘responsible drinking’! Fury as woke WHO advisers claim phrase unfairly ‘shames’ drunken thugs EXCLUSIVE: The wording ignores the ‘inherent risks’ of boozing, WHO says READ MORE: No amount of alcohol is safe, WHO experts warn The World Health Organization has come under fire for claiming the phrase ‘responsible drinking’ stigmatises […]

Sick of bad dreams? Here's how you can lower your chances of having them

Having a bad dream can spoil a whole night’s worth of sleep. Waking up in a cold sweat, trying to catch your breath as you remind yourself that dreams aren’t real, fumbling for a light switch in the dark, trying to think of something, anything else to get yourself back to sleep… it’s utterly miserable. […]

Australia targets Big Tobacco in crackdown on vaping

Australia announced a sweeping crackdown on vaping Tuesday, accusing tobacco companies of hooking the next “generation of nicotine addicts” by deliberately targeting teenagers. Billed as the country’s largest anti-smoking reforms in a decade, Australia will ban single-use disposable vapes, halt imports of non-prescription versions, and restrict how much nicotine e-cigarettes may contain. Australia has long […]

FDA Approves Abilify Asimtufii

FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults April 28, 2023 — Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Abilify Asimtufii® (aripiprazole) extended-release injectable […]